布地奈德/福莫特罗治疗咳嗽变异性哮喘的临床意义

Clinical significance of budesonide/formoterol in the treatment of cough variant asthma

目的探讨布地奈德/福莫特罗治疗咳嗽变异性哮喘的临床意义。方法 32例咳嗽变异性哮喘患者,患者均采用布地奈德/福莫特罗治疗,观察患者治疗8周后的疗效。结果 32例咳嗽变异性哮喘患者治疗8周后,有26例患者咳嗽症状明显好转,占81.25%;6例咳嗽症状有减轻,但效果不理想,占18.75%。结论布地奈德/福莫特罗治疗咳嗽变异性哮喘效果良好,可减小咳嗽变异哮喘发展为典型哮喘的几率。

Objective To investigate the clinical significance of budesonide/formoterol in the treatment of cough variant asthma.Methods A total of 32 cases of cough variant asthma patients were treated with budesonide/formoterol,and their efficacy after 8 weeks of treatment were observed.Results 32 patients with cough variant asthma had symptoms of cough significantly improved after 8 weeks of treatment,accounting for 81.25%,and 6 patients had relieved symptoms of cough,but the effect was unsatisfactory,accounting for 18.75%.Conclusion Budesonide/formoterol is effective in treating cough variant asthma,thereby reducing probability of cough variation asthma developing into typical asthma.